# Shanghai Wonder Pharmaceutical Co., Ltd. – FDA Inspection, Mar 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/shanghai-wonder-pharmaceutical-co-ltd/40e08812-8902-4a79-bf49-7674f9143718
Source feed: FDA_Inspections

> FDA inspection 1269021 of Shanghai Wonder Pharmaceutical Co., Ltd., March 14, 2025. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269021
- Company Name: Shanghai Wonder Pharmaceutical Co., Ltd.
- Inspection Date: 2025-03-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1077031 - 2018-12-06
- FDA Inspection 926659 - 2015-04-17
- FDA Inspection 749000 - 2011-09-29

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)

Company: https://www.keypedia.com/companies/shanghai-wonder-pharmaceutical-co-ltd/edd00479-6622-48ca-8618-08ec536f77ec

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c